000			01361 a2200361 4500
005			20250513033627.0
264		0	_c19950810
008			199508s 0 0 eng d
022			_a0268-3369
040			_aNLM _beng _cNLM
100	1		_aSykes, M
245	0	0	_aIL-2-induced GVHD protection is not inhibited by cyclosporine and is maximal when IL-2 is given over a 25 h period beginning on the day following bone marrow transplantation. _h[electronic resource]
260			_bBone marrow transplantation _cMar 1995
300			_a395-9 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAnimals
650	0	4	_aBone Marrow Transplantation
650	0	4	_aCyclosporine _xadministration & dosage
650	0	4	_aDrug Administration Schedule
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFemale
650	0	4	_aGraft vs Host Disease _xmortality
650	0	4	_aInterleukin-2 _xadministration & dosage
650	0	4	_aMice
650	0	4	_aMice, Inbred A
650	0	4	_aMice, Inbred C57BL
650	0	4	_aSpecific Pathogen-Free Organisms
650	0	4	_aSurvival Rate
650	0	4	_aTransplantation, Homologous
700	1		_aPearson, D A
700	1		_aSzot, G L
773	0		_tBone marrow transplantation _gvol. 15 _gno. 3 _gp. 395-9
999			_c7599002 _d7599002